XOMA |
XOMA Royalty Corp |
Jan 24, 2025 |
4 |
-$17M |
4 |
Jan 28, 2025 |
10%+ Owner |
OLMA |
Olema Pharmaceuticals, Inc. |
Jan 10, 2025 |
6 |
$0 |
4 |
Jan 14, 2025 |
Director, Other* |
PVLA |
PALVELLA THERAPEUTICS, INC. |
Dec 13, 2024 |
3 |
$0 |
4 |
Dec 17, 2024 |
Other* |
OLMA |
Olema Pharmaceuticals, Inc. |
Dec 4, 2024 |
9 |
$22.4M |
4 |
Dec 4, 2024 |
Director, Other* |
FDMT |
4D Molecular Therapeutics, Inc. |
Nov 8, 2024 |
6 |
$0 |
4 |
Nov 13, 2024 |
Other* |
THRD |
Third Harmonic Bio, Inc. |
Oct 29, 2024 |
3 |
-$14.3M |
4 |
Oct 31, 2024 |
Other* |
ELDN |
Eledon Pharmaceuticals, Inc. |
Oct 29, 2024 |
3 |
$17.3M |
4 |
Oct 31, 2024 |
10%+ Owner |
MLTX |
MoonLake Immunotherapeutics |
Oct 4, 2024 |
3 |
-$100M |
4 |
Oct 8, 2024 |
Director, 10%+ Owner |
KYMR |
Kymera Therapeutics, Inc. |
Aug 20, 2024 |
2 |
$14.6M |
4 |
Aug 22, 2024 |
Director, Other* |
FDMT |
4D Molecular Therapeutics, Inc. |
Jul 22, 2024 |
0 |
$0 |
3 |
Aug 1, 2024 |
10%+ Owner |
KYMR |
Kymera Therapeutics, Inc. |
Jun 18, 2024 |
1 |
$0 |
4 |
Jun 28, 2024 |
Director, Other* |
OLMA |
Olema Pharmaceuticals, Inc. |
Jun 14, 2024 |
1 |
$0 |
4 |
Jun 18, 2024 |
Director, 10%+ Owner |
MLTX |
MoonLake Immunotherapeutics |
Jun 6, 2024 |
1 |
$0 |
4 |
Jun 10, 2024 |
Director, 10%+ Owner |
ELDN |
Eledon Pharmaceuticals, Inc. |
May 9, 2024 |
6 |
$0 |
4 |
May 13, 2024 |
10%+ Owner |
RAIN |
Rain Oncology Inc. |
Jan 25, 2024 |
8 |
$0 |
4 |
Jan 29, 2024 |
Director, Other* |
ALLK |
Allakos Inc. |
Jan 16, 2024 |
0 |
$0 |
3 |
Jan 26, 2024 |
10%+ Owner |
KYMR |
Kymera Therapeutics, Inc. |
Jan 5, 2024 |
3 |
$24.7M |
4 |
Jan 9, 2024 |
Director, Other* |
PNT |
POINT Biopharma Global Inc. |
Dec 18, 2023 |
3 |
-$214M |
4 |
Dec 20, 2023 |
Former 10% Owner |
RPTX |
Repare Therapeutics Inc. |
Nov 15, 2023 |
6 |
$6.25M |
4 |
Nov 17, 2023 |
10%+ Owner |
KYMR |
Kymera Therapeutics, Inc. |
Nov 2, 2023 |
6 |
$5.3M |
4 |
Nov 6, 2023 |
Director, Other* |
PNT |
POINT Biopharma Global Inc. |
Nov 2, 2023 |
0 |
$0 |
3 |
Nov 6, 2023 |
10%+ Owner |
RPTX |
Repare Therapeutics Inc. |
Nov 2, 2023 |
3 |
$2.82M |
4 |
Nov 3, 2023 |
10%+ Owner |
ENGN |
enGene Holdings Inc. |
Oct 31, 2023 |
0 |
$0 |
3 |
Nov 13, 2023 |
10%+ Owner |
OLMA |
Olema Pharmaceuticals, Inc. |
Sep 12, 2023 |
4 |
$14.8M |
4 |
Sep 14, 2023 |
Director, 10%+ Owner |
CTIC |
CTI BIOPHARMA CORP |
Jun 26, 2023 |
18 |
-$80.6M |
4 |
Jun 28, 2023 |
Director, Other*, 10%+ Owner |
OLMA |
Olema Pharmaceuticals, Inc. |
Jun 16, 2023 |
1 |
$0 |
4 |
Jun 21, 2023 |
Director, 10%+ Owner |
KYMR |
Kymera Therapeutics, Inc. |
Jun 15, 2023 |
1 |
$0 |
4 |
Jun 20, 2023 |
Director, Other* |
MLTX |
MoonLake Immunotherapeutics |
Jun 8, 2023 |
1 |
$0 |
4 |
Jun 12, 2023 |
Director, 10%+ Owner |
XOMA |
XOMA Corp |
May 17, 2023 |
1 |
$0 |
4 |
May 19, 2023 |
Director, Other*, 10%+ Owner |
PIRS |
PIERIS PHARMACEUTICALS, INC. |
May 11, 2023 |
0 |
$0 |
3 |
May 22, 2023 |
10%+ Owner |
GPCR |
Structure Therapeutics Inc. |
May 10, 2023 |
6 |
$0 |
4 |
May 12, 2023 |
10%+ Owner |
ELDN |
Eledon Pharmaceuticals, Inc. |
May 5, 2023 |
9 |
$0 |
4 |
May 9, 2023 |
10%+ Owner |
CTIC |
CTI BIOPHARMA CORP |
Apr 5, 2023 |
1 |
$0 |
4 |
Apr 7, 2023 |
Director, Other*, 10%+ Owner |
GPCR |
Structure Therapeutics Inc. |
Feb 3, 2023 |
0 |
$0 |
3 |
Feb 13, 2023 |
10%+ Owner |
CGEM |
Cullinan Oncology, Inc. |
Jan 19, 2023 |
6 |
$0 |
4 |
Jan 19, 2023 |
10%+ Owner |
KYMR |
Kymera Therapeutics, Inc. |
Jan 11, 2023 |
4 |
$1.25M |
4 |
Jan 13, 2023 |
Director, Other* |
XOMA |
XOMA Corp |
Jan 5, 2023 |
4 |
$421K |
4 |
Jan 9, 2023 |
Director, Other*, 10%+ Owner |
THRD |
Third Harmonic Bio, Inc. |
Dec 20, 2022 |
3 |
$879K |
4 |
Dec 22, 2022 |
10%+ Owner |
THRD |
Third Harmonic Bio, Inc. |
Dec 19, 2022 |
0 |
$0 |
3 |
Dec 22, 2022 |
10%+ Owner |
RAIN |
Rain Therapeutics Inc. |
Nov 8, 2022 |
3 |
$9.97M |
4 |
Nov 10, 2022 |
Director, Other*, 10%+ Owner |
XOMA |
XOMA Corp |
Sep 23, 2022 |
6 |
$409K |
4 |
Sep 27, 2022 |
Director, Other*, 10%+ Owner |
XOMA |
XOMA Corp |
Sep 14, 2022 |
4 |
$991K |
4 |
Sep 16, 2022 |
Director, Other*, 10%+ Owner |
KYMR |
Kymera Therapeutics, Inc. |
Aug 22, 2022 |
3 |
$14.2M |
4 |
Aug 23, 2022 |
Director, Other* |
CTIC |
CTI BIOPHARMA CORP |
Aug 9, 2022 |
12 |
-$52M |
4 |
Aug 11, 2022 |
Director, Other*, 10%+ Owner |
EPIX |
ESSA Pharma Inc. |
Jul 11, 2022 |
0 |
$0 |
3 |
Jul 21, 2022 |
10%+ Owner |
FDMT |
4D Molecular Therapeutics, Inc. |
Jun 16, 2022 |
0 |
$0 |
3 |
Jun 27, 2022 |
10%+ Owner |
KYMR |
Kymera Therapeutics, Inc. |
Jun 15, 2022 |
1 |
$0 |
4 |
Jun 17, 2022 |
Director, Other* |
RPTX |
Repare Therapeutics Inc. |
Jun 13, 2022 |
3 |
$1.9M |
4 |
Jun 15, 2022 |
10%+ Owner |
OLMA |
Olema Pharmaceuticals, Inc. |
Jun 10, 2022 |
2 |
$807K |
4 |
Jun 14, 2022 |
Director, 10%+ Owner |
RPTX |
Repare Therapeutics Inc. |
Jun 2, 2022 |
9 |
$21.9M |
4 |
Jun 6, 2022 |
10%+ Owner |
CGEM |
Cullinan Oncology, Inc. |
Jun 1, 2022 |
3 |
$8.26M |
4 |
Jun 3, 2022 |
10%+ Owner |
KYMR |
Kymera Therapeutics, Inc. |
May 26, 2022 |
6 |
$4.15M |
4 |
May 31, 2022 |
Director, Other* |
KYMR |
Kymera Therapeutics, Inc. |
May 20, 2022 |
3 |
$141K |
4 |
May 24, 2022 |
Director, Other* |
XOMA |
XOMA Corp |
May 18, 2022 |
1 |
$0 |
4 |
May 20, 2022 |
Director, Other*, 10%+ Owner |
RPTX |
Repare Therapeutics Inc. |
May 18, 2022 |
3 |
$3.57M |
4 |
May 20, 2022 |
10%+ Owner |
CGEM |
Cullinan Oncology, Inc. |
May 12, 2022 |
5 |
$10.1M |
4 |
May 16, 2022 |
10%+ Owner |
KYMR |
Kymera Therapeutics, Inc. |
May 5, 2022 |
6 |
$4.87M |
4 |
May 9, 2022 |
Director, Other* |
MLTX |
MoonLake Immunotherapeutics |
Apr 5, 2022 |
0 |
$0 |
3 |
Apr 15, 2022 |
Director, 10%+ Owner |
CGEM |
Cullinan Oncology, Inc. |
Apr 1, 2022 |
2 |
$2.97M |
4 |
Apr 5, 2022 |
10%+ Owner |
CTIC |
CTI BIOPHARMA CORP |
Mar 9, 2022 |
1 |
$0 |
4 |
Mar 11, 2022 |
Director, Other*, 10%+ Owner |
KYMR |
Kymera Therapeutics, Inc. |
Jan 27, 2022 |
4 |
$5.08M |
4 |
Jan 31, 2022 |
Director, Other* |
VSTM |
Verastem, Inc. |
Jan 25, 2022 |
0 |
$0 |
3 |
Feb 7, 2022 |
10%+ Owner |
KYMR |
Kymera Therapeutics, Inc. |
Jan 24, 2022 |
2 |
$10.3M |
4 |
Jan 26, 2022 |
Director, Other* |
ELDN |
Eledon Pharmaceuticals, Inc. |
Jan 20, 2022 |
0 |
$0 |
3 |
Jan 31, 2022 |
10%+ Owner |
RPTX |
Repare Therapeutics Inc. |
Jan 19, 2022 |
3 |
$14.1M |
4 |
Jan 21, 2022 |
10%+ Owner |
RAIN |
Rain Therapeutics Inc. |
Jan 6, 2022 |
4 |
$6.69M |
4 |
Jan 10, 2022 |
Director, Other*, 10%+ Owner |
CGEM |
Cullinan Oncology, Inc. |
Dec 31, 2021 |
0 |
$0 |
3 |
Jan 10, 2022 |
10%+ Owner |
OLMA |
Olema Pharmaceuticals, Inc. |
Nov 30, 2021 |
3 |
$6.95M |
4 |
Dec 2, 2021 |
Director, 10%+ Owner |
RPTX |
Repare Therapeutics Inc. |
Oct 28, 2021 |
0 |
$0 |
3 |
Nov 8, 2021 |
10%+ Owner |
MRUS |
Merus N.V. |
Oct 7, 2021 |
6 |
-$31.2M |
4 |
Oct 8, 2021 |
10%+ Owner |
RAIN |
Rain Therapeutics Inc. |
Sep 21, 2021 |
3 |
$154K |
4 |
Sep 23, 2021 |
Director, Other*, 10%+ Owner |
RAIN |
Rain Therapeutics Inc. |
Sep 13, 2021 |
3 |
$6.47M |
4 |
Sep 15, 2021 |
Director, Other*, 10%+ Owner |
MRUS |
Merus N.V. |
Jul 2, 2021 |
3 |
-$45.4M |
4 |
Jul 7, 2021 |
10%+ Owner |
RAIN |
Rain Therapeutics Inc. |
Jul 1, 2021 |
6 |
$9.08M |
4 |
Jul 6, 2021 |
Director, Other*, 10%+ Owner |
KYMR |
Kymera Therapeutics, Inc. |
Jul 1, 2021 |
3 |
$25.6M |
4 |
Jul 6, 2021 |
Director, Other* |
KYMR |
Kymera Therapeutics, Inc. |
Jun 16, 2021 |
1 |
$0 |
4 |
Jun 21, 2021 |
Director, Other* |
RAIN |
Rain Therapeutics Inc. |
May 21, 2021 |
6 |
$1.97M |
4 |
May 25, 2021 |
Director, Other*, 10%+ Owner |
XOMA |
XOMA Corp |
May 19, 2021 |
1 |
$0 |
4 |
May 21, 2021 |
Director, Other*, 10%+ Owner |
RAIN |
Rain Therapeutics Inc. |
May 18, 2021 |
6 |
$3.46M |
4 |
May 20, 2021 |
Director, Other* |
RAIN |
Rain Therapeutics Inc. |
May 13, 2021 |
3 |
$827K |
4 |
May 17, 2021 |
Director, Other* |
RAIN |
Rain Therapeutics Inc. |
Apr 23, 2021 |
9 |
$19.1M |
4/A |
May 17, 2021 |
Director, Other* |
OLMA |
Olema Pharmaceuticals, Inc. |
Mar 31, 2021 |
1 |
$0 |
4 |
May 26, 2021 |
Director, 10%+ Owner |